132
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study*

, &
Pages 1037-1043 | Accepted 12 Feb 2009, Published online: 16 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ewa Mrukwa-Kominek, Marta Misiuk-Hojlo, Adrienne Csutak, Ingeborg Stalmans & Gerhard Garhofer. (2023) A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension. Current Medical Research and Opinion 39:5, pages 775-783.
Read now
Nevbahar Tamçelik, Belgin Izgi, Ahmet Temel, Nilgun Yildirim, Mehmet Okka, Altan Özcan, Nurşen Yüksel, Ufuk Elgin, Çiğdem Altan & Baris Ozer. (2017) Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 11, pages 723-731.
Read now
Katrin Lorenz, Klaus Rosbach, Andreas Matt & Norbert Pfeiffer. (2011) Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension. Clinical Ophthalmology 5, pages 1745-1750.
Read now
Gerrett Brief, Tobias Lammich, Edgar Nagel, Sabine Pfennigsdorf, Christoph W Spraul & Selwyn Ho. (2010) Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment. Clinical Ophthalmology 4, pages 1125-1129.
Read now

Articles from other publishers (5)

Xinghuai Sun, Ke Yao, Qinghuai Liu, Hong Zhang, Xiaoli Xing, Aiwu Fang, Xuanchu Duan, Minbin Yu, Michelle Y. Chen, Jingyuan Yang & Margot L. Goodkin. (2022) Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and Therapy 12:1, pages 341-353.
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 612 661 .
S.M. Kosakyan, O.V. Robustova, A.M. Bessmertny, O.M. Kalinina & L.V. Vasilenkova. (2020) Effectiveness and safety of drug combination therapy in patients with advanced primary open-angle glaucoma. Vestnik oftal'mologii 136:5, pages 96.
Crossref
Kaidi Wang, Li Xu, Zhilan Yuan, Ke Yao, Junmei Zhao, Liang Xu, Aiwu Fang, Mingzhi Zhang, Lingling Wu, Jian Ji, Jiamin Hou, Qing Liu & Xinghuai Sun. (2014) Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China. BMC Ophthalmology 14:1.
Crossref
Alfonso García-López, José A Paczka, Jesús Jiménez-Román & Curt Hartleben. (2014) Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study. BMC Ophthalmology 14:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.